Lunsumio Concentrate
Product Images NDC 50242-159

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lunsumio (NDC 50242-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lunsumio 01)

A logarithmic line graph showing Mosunetuzumab-concentration versus time in days. The chart illustrates the geometric mean concentration curve with a shaded area depicting the 90th percentile prediction interval over approximately 168 days.*

FDA Label Image

Principal Display Panel (30 mg/30 mL Vial Carton)

Label for Lunsumio (mosunetuzumab-axgb) Injection concentrate, 30 mg/30 mL (1 mg/mL) for intravenous infusion. It is a single-dose vial. The label includes usage instructions to discard unused portions and to dispense the enclosed Medication Guide to each patient. Manufactured by Genentech, Inc.*

FDA Label Image

Principal Display Panel (1 mg/mL Vial Carton)

Label of Lunsumio (mosunetuzumab-axgb) injection concentrate in a 1 mg/mL strength. The label indicates it is for intravenous infusion only, supplied as a single-dose vial, and advises discarding any unused portion. The manufacturer is Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.